{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T02:59:23Z","timestamp":1785553163339,"version":"3.56.0"},"reference-count":42,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,3,12]],"date-time":"2021-03-12T00:00:00Z","timestamp":1615507200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,3,12]],"date-time":"2021-03-12T00:00:00Z","timestamp":1615507200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Nowadays, prostate cancer is the most widespread tumour in worldwide male population. Actually, brachytherapy is the most advanced radiotherapy strategy for the local treatment of prostate cancer. It consists in the placing of radioactive sources closed to the tumour side thus killing cancer cells. However, brachytherapy causes the same adverse effects of external-beam radiotherapy. Therefore, alternative treatment approaches are required for enhancing radiotherapy effectiveness and reducing toxic symptoms. Nanostructured exfoliated black phosphorus (2D BP) may represent a strategic tool for local cancer therapy because of its capability to induce singlet oxygen production and act as photosensitizer. Hence, we investigated 2D BP in vitro effect on healthy and cancer prostate cell behavior. 2D BP was obtained through liquid exfoliation. 2D BP effect on healthy and cancer prostate cell behaviors was analyzed by investigating cell viability, oxidative stress and inflammatory marker expression. 2D BP inhibited prostate cancer cell survival, meanwhile promoted healthy prostate cell survival in vitro by modulating oxidative stress and immune response with and without near-infrared light (NIR)-irradiation. Nanostructured 2D BP is able to inhibit in vitro prostate cancer cells survival and preserve healthy prostate cell vitality through the control of oxidative stress and immune response, respectively.<\/jats:p>","DOI":"10.1038\/s41598-021-85310-6","type":"journal-article","created":{"date-parts":[[2021,3,12]],"date-time":"2021-03-12T11:07:02Z","timestamp":1615547222000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["2D exfoliated black phosphorus influences healthy and cancer prostate cell behaviors"],"prefix":"10.1038","volume":"11","author":[{"given":"Ines","family":"Fasolino","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandra","family":"Soriente","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Caporali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manuel","family":"Serrano-Ruiz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maurizio","family":"Peruzzini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luigi","family":"Ambrosio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Grazia","family":"Raucci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,3,12]]},"reference":[{"key":"85310_CR1","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1093\/jncimonographs\/lgs035","volume":"2012","author":"OW Brawley","year":"2012","unstructured":"Brawley, O. W. Trends in prostate cancer in the United States. J. Natl. Cancer Inst. Monogr. 2012, 152\u2013156 (2012).","journal-title":"J. Natl. Cancer Inst. Monogr."},{"key":"85310_CR2","doi-asserted-by":"publisher","first-page":"a030452","DOI":"10.1101\/cshperspect.a030452","volume":"7","author":"H Heemers","year":"2017","unstructured":"Heemers, H., Dai, C. & Sharifi, N. Androgen signaling in prostate cancer. Cold Spring Harb. Perspect. Med. 7, a030452 (2017).","journal-title":"Cold Spring Harb. Perspect. Med."},{"key":"85310_CR3","doi-asserted-by":"publisher","first-page":"699","DOI":"10.1038\/nrd.2016.120","volume":"15","author":"TA Yap","year":"2016","unstructured":"Yap, T. A. et al. Drug discovery in advanced prostate cancer: translating biology into therapy. Nat. Rev. Drug Discov. 15, 699\u2013718 (2016).","journal-title":"Nat. Rev. Drug Discov."},{"key":"85310_CR4","doi-asserted-by":"publisher","first-page":"E1359","DOI":"10.3390\/ijms19051359","volume":"19","author":"E Nevedomskaya","year":"2018","unstructured":"Nevedomskaya, E., Baumgart, S. J. & Haendler, B. Recent advances in prostate cancer treatment and drug discovery. Int. J. Mol. Sci. 19, E1359. https:\/\/doi.org\/10.3390\/ijms19051359 (2018).","journal-title":"Int. J. Mol. Sci."},{"key":"85310_CR5","doi-asserted-by":"publisher","first-page":"581","DOI":"10.5114\/jcb.2017.72607","volume":"9","author":"J Skowronek","year":"2017","unstructured":"Skowronek, J. Current status of brachytherapy in cancer treatment: short overview. J. Contemp. Brachytherapy 9, 581\u2013589. https:\/\/doi.org\/10.5114\/jcb.2017.72607 (2017).","journal-title":"J. Contemp. Brachytherapy"},{"key":"85310_CR6","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1002\/(SICI)1098-2388(199711\/12)13:6<431::AID-SSU7>3.0.CO;2-B","volume":"13","author":"HH Holm","year":"1997","unstructured":"Holm, H. H. The history of interstitial brachytherapy of prostatic cancer. Semin. Surg. Oncol. 13, 431\u2013437 (1997).","journal-title":"Semin. Surg. Oncol."},{"key":"85310_CR7","doi-asserted-by":"publisher","first-page":"341","DOI":"10.21037\/tau.2017.12.15","volume":"7","author":"BJ Stish","year":"2018","unstructured":"Stish, B. J. et al. Low dose rate prostate brachytherapy. Transl. Androl. Urol. 7, 341\u2013356. https:\/\/doi.org\/10.21037\/tau.2017.12.15 (2018).","journal-title":"Transl. Androl. Urol."},{"issue":"1","key":"85310_CR8","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/s0360-3016(03)00784-3","volume":"58","author":"PA Kupelian","year":"2004","unstructured":"Kupelian, P. A. et al. Radical prostatectomy, external beam radiotherapy < 72Gy, external beam radiotherapy > or = 72 Gy permanent seed implantation, or combined seeds\/external beam radiotherapy for stage T1\u2013T2 prostate cancer. Int. J. Radiat. Oncol. Biol. Phys. 58(1), 25\u201333. https:\/\/doi.org\/10.1016\/s0360-3016(03)00784-3 (2004).","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"85310_CR9","doi-asserted-by":"publisher","first-page":"1405","DOI":"10.1016\/j.ijrobp.2008.10.091","volume":"74","author":"GA Viani","year":"2009","unstructured":"Viani, G. A., Stefano, E. J. & Afonso, S. L. Higher-than-conventional radiation doses in localized prostate cancer treatment: a meta-analysis of randomized. Controlled Trials Int. J. Radiat. Oncol. Biol. Phys. 74, 1405\u20131418 (2009).","journal-title":"Controlled Trials Int. J. Radiat. Oncol. Biol. Phys."},{"key":"85310_CR10","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1016\/j.meddos.2003.09.005","volume":"29","author":"AB Jani","year":"2004","unstructured":"Jani, A. B. et al. Optimal radiotherapy for prostate cancer: predictions for conventional external beam, IMRT, and brachytherapy from radiobiologic models. Med. Dosim. 29, 42\u201348 (2004).","journal-title":"Med. Dosim."},{"key":"85310_CR11","doi-asserted-by":"publisher","first-page":"279","DOI":"10.4240\/wjgs.v7.i11.279","volume":"7","author":"KA Morris","year":"2015","unstructured":"Morris, K. A. & Haboubi, N. Y. Pelvic radiation therapy: between delight and disaster. World J. Gastrointest. Surg. 7, 279\u2013288 (2015).","journal-title":"World J. Gastrointest. Surg."},{"key":"85310_CR12","doi-asserted-by":"publisher","first-page":"250","DOI":"10.3322\/caac.20114","volume":"61","author":"P Agostinis","year":"2011","unstructured":"Agostinis, P. et al. Photodynamic therapy of cancer: an update. CA Cancer J. Clin. 61, 250\u2013281 (2011).","journal-title":"CA Cancer J. Clin."},{"key":"85310_CR13","doi-asserted-by":"publisher","first-page":"3279","DOI":"10.3390\/cancers3033279","volume":"3","author":"M Arruebo","year":"2011","unstructured":"Arruebo, M. et al. Assessment of the evolution of cancer treatment therapies. Cancers (Basel). 3, 3279\u20133330 (2011).","journal-title":"Cancers (Basel)."},{"issue":"8","key":"85310_CR14","doi-asserted-by":"publisher","first-page":"1005","DOI":"10.7150\/thno.22573.eCollection","volume":"2018","author":"JR Choi","year":"2018","unstructured":"Choi, J. R. et al. Black phosphorus and its biomedical applications. Theranostics 2018(8), 1005\u20131026. https:\/\/doi.org\/10.7150\/thno.22573.eCollection (2018).","journal-title":"Theranostics"},{"key":"85310_CR15","doi-asserted-by":"publisher","first-page":"13991","DOI":"10.1002\/chem.201502006","volume":"21","author":"NM Latiff","year":"2015","unstructured":"Latiff, N. M., Teo, W. Z., Sofer, Z., Fisher, A. C. & Pumera, M. The cytotoxicity of layered black phosphorus. Chem. Eur. J. 21, 13991\u201313995 (2015).","journal-title":"Chem. Eur. J."},{"key":"85310_CR16","doi-asserted-by":"publisher","first-page":"978","DOI":"10.1016\/j.msec.2018.12.146","volume":"97","author":"S Anju","year":"2019","unstructured":"Anju, S., Ashtami, J. & Mohanan, P. V. Black phosphorus, a prospective graphene substitute for biomedical applications. Mater. Sci. Eng. C. 97, 978\u2013993 (2019).","journal-title":"Mater. Sci. Eng. C."},{"key":"85310_CR17","doi-asserted-by":"publisher","first-page":"245404","DOI":"10.1103\/PhysRevB.94.245404","volume":"94","author":"N Hermsworth","year":"2016","unstructured":"Hermsworth, N. et al. Dephasing in strongly anisotropic black phosphorus. Phys. Rev. B 94, 245404 (2016).","journal-title":"Phys. Rev. B"},{"key":"85310_CR18","doi-asserted-by":"publisher","first-page":"1500441","DOI":"10.1002\/admi.201500441","volume":"3","author":"M Serrano-Ruiz","year":"2016","unstructured":"Serrano-Ruiz, M. et al. The role of water in the preparation and stabilization of high-quality phosphorene flakes. Adv. Mater. Interfaces. 3, 1500441 (2016).","journal-title":"Adv. Mater. Interfaces."},{"issue":"35","key":"85310_CR19","doi-asserted-by":"publisher","first-page":"11376","DOI":"10.1021\/jacs.5b06025","volume":"137","author":"H Wang","year":"2015","unstructured":"Wang, H. et al. Ultrathin black phosphorus nanosheets for efficient singlet oxygen generation. J. Am. Chem. Soc. 137(35), 11376\u201311382 (2015).","journal-title":"J. Am. Chem. Soc."},{"key":"85310_CR20","doi-asserted-by":"publisher","first-page":"9333","DOI":"10.1021\/acsami.8b21592","volume":"11","author":"MG Raucci","year":"2019","unstructured":"Raucci, M. G. et al. Exfoliated black phosphorus promotes in vitro bone regeneration and suppresses osteosarcoma progression through cancer-related inflammation inhibition. ACS Appl. Mater. Interfaces 11, 9333\u20139342. https:\/\/doi.org\/10.1021\/acsami.8b21592 (2019).","journal-title":"ACS Appl. Mater. Interfaces"},{"issue":"1","key":"85310_CR21","doi-asserted-by":"publisher","first-page":"e17","DOI":"10.14440\/jbm.2015","volume":"2","author":"D Cunningham","year":"2015","unstructured":"Cunningham, D. & You, Z. In vitro and in vivo model systems used in prostate cancer research. J. Biol. Methods 2(1), e17. https:\/\/doi.org\/10.14440\/jbm.2015 (2015).","journal-title":"J. Biol. Methods"},{"issue":"50","key":"85310_CR22","doi-asserted-by":"publisher","first-page":"82783","DOI":"10.18632\/oncotarget.12635","volume":"7","author":"MS Al Fayi","year":"2016","unstructured":"Al Fayi, M. S. et al. The increased expression of fatty acid-binding protein 9 in prostate cancer and its prognostic significance. Oncotarget 7(50), 82783\u201382797 (2016).","journal-title":"Oncotarget"},{"key":"85310_CR23","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1002\/jbm.b.31495","volume":"92","author":"MG Raucci","year":"2010","unstructured":"Raucci, M. G., Adesanya, K., Di Silvio, L., Catauro, M. & Ambrosio, L. The biocompatibility of silver-containing Na2O\u00b7CaO\u00b72SiO2 glass prepared by sol\u2013gel method: In vitro studies. J. Biomed. Mater. Res. B. 92, 102\u2013110 (2010).","journal-title":"J. Biomed. Mater. Res. B."},{"key":"85310_CR24","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1038\/s12276-018-0184-0","volume":"50","author":"T Liang","year":"2018","unstructured":"Liang, T. et al. FAM46B inhibits cell proliferation and cell cycle progression in prostate cancer through ubiquitination of \u03b2-catenin. Exp. Mol. Med. 50, 163 (2018).","journal-title":"Exp. Mol. Med."},{"key":"85310_CR25","doi-asserted-by":"publisher","first-page":"479","DOI":"10.3109\/10715761003667554","volume":"44","author":"GY Liou","year":"2010","unstructured":"Liou, G. Y. & Storz, P. Reactive oxygen species in cancer. Free Radic. Res. 44, 479\u2013496 (2010).","journal-title":"Free Radic. Res."},{"key":"85310_CR26","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1007\/978-94-024-1170-6_5","volume":"1011","author":"Y Li","year":"2017","unstructured":"Li, Y., Wan, Y. Y. & Zhu, B. Immune cell metabolism in tumor microenvironment. Adv. Exp. Med. Biol. 1011, 163\u2013196 (2017).","journal-title":"Adv. Exp. Med. Biol."},{"key":"85310_CR27","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1016\/j.freeradbiomed.2014.04.035","volume":"79","author":"LM Bystrom","year":"2015","unstructured":"Bystrom, L. M. & Rivella, S. Cancer cells with irons in the fire. Free Radic. Biol. Med. 79, 337\u2013342 (2015).","journal-title":"Free Radic. Biol. Med."},{"key":"85310_CR28","doi-asserted-by":"publisher","first-page":"978","DOI":"10.1016\/j.msec.2018.12.146","volume":"97","author":"S Anju","year":"2019","unstructured":"Anju, S., Ashtami, J. & Mohanan, P. V. Black phosphorus, a prospective graphene substitute for biomedical applications. Mater. Sci. Eng. C Mater. Biol. Appl. 97, 978\u2013993 (2019).","journal-title":"Mater. Sci. Eng. C Mater. Biol. Appl."},{"issue":"3","key":"85310_CR29","doi-asserted-by":"publisher","first-page":"728","DOI":"10.1002\/jbm.a.35946","volume":"105","author":"IM Martinez Paino","year":"2017","unstructured":"Martinez Paino, I. M. & Santos, F. J. Biocompatibility and toxicology effects of graphene oxide in cancer, normal, and primary immune cells. Biomed. Mater. Res. A. 105(3), 728\u2013736 (2017).","journal-title":"Biomed. Mater. Res. A."},{"key":"85310_CR30","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1039\/C8NH00318A","volume":"4","author":"V Palmieri","year":"2019","unstructured":"Palmieri, V., Perini, G., De Spirito, M. & Papi, M. Graphene oxide touches blood: in vivo interactions of bio-coronated 2D materials. Nanoscale Horiz. 4, 273\u2013290 (2019).","journal-title":"Nanoscale Horiz."},{"key":"85310_CR31","doi-asserted-by":"publisher","first-page":"7366","DOI":"10.1158\/0008-5472.CAN-09-0758","volume":"69","author":"H Pu","year":"2009","unstructured":"Pu, H. et al. Dysfunctional transforming growth factor-beta receptor II accelerates prostate tumorigenesis in the TRAMP mouse model. Cancer Res. 69, 7366\u20137374 (2009).","journal-title":"Cancer Res."},{"key":"85310_CR32","doi-asserted-by":"publisher","first-page":"1329","DOI":"10.1515\/BC.2006.166","volume":"387","author":"R Brigelius-Floh\u00e9","year":"2006","unstructured":"Brigelius-Floh\u00e9, R. Glutathione peroxidases and redox-regulated transcription factors. Biol. Chem. 387, 1329\u20131335 (2006).","journal-title":"Biol. Chem."},{"key":"85310_CR33","doi-asserted-by":"publisher","first-page":"2465","DOI":"10.1158\/0008-5472.CAN-09-2782","volume":"70","author":"I Ben Sahra","year":"2010","unstructured":"Ben Sahra, I. et al. Targeting cancer cell metabolism: the combinationof metformin and 2-deoxyglucose induces p53-dependent apoptosis in prostate cancer cells. Cancer Res. 70, 2465\u20132475 (2010).","journal-title":"Cancer Res."},{"key":"85310_CR34","doi-asserted-by":"publisher","first-page":"7863","DOI":"10.1038\/sj.onc.1208069","volume":"23","author":"M Herrant","year":"2004","unstructured":"Herrant, M. et al. Cleavage of Mcl-1 by caspases impaired its ability to counteract Bim-induced apoptosis. Oncogene 23, 7863\u20137873 (2004).","journal-title":"Oncogene"},{"issue":"12","key":"85310_CR35","doi-asserted-by":"publisher","first-page":"2977","DOI":"10.1016\/j.bbamcr.2016.09.012","volume":"1863","author":"MM Redza-Dutordoir","year":"2016","unstructured":"Redza-Dutordoir, M. M. & Averill-Bates, D. A. Activation of apoptosis signalling pathways by reactive oxygen species. Biochim. Biophys. Acta Mol. Cell Res. 1863(12), 2977\u20132992 (2016).","journal-title":"Biochim. Biophys. Acta Mol. Cell Res."},{"key":"85310_CR36","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1038\/s41419-019-1414-7","volume":"10","author":"T Druck","year":"2019","unstructured":"Druck, T. et al. Fhit-Fdxr interaction in the mitochondria: modulation of reactive oxygen species generation and apoptosis in cancer cells. Cell Death Dis. 10, 147 (2019).","journal-title":"Cell Death Dis."},{"key":"85310_CR37","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1038\/38525","volume":"389","author":"K Polyak","year":"1997","unstructured":"Polyak, K. et al. A model for p53-induced apoptosis. Nature 389, 300\u2013305 (1997).","journal-title":"Nature"},{"key":"85310_CR38","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1615\/CritRevOncog.2018025946","volume":"23","author":"L Chaiswing","year":"2018","unstructured":"Chaiswing, L., Weiss, H. L., Jayswal, R. D., Clair, D. K. S. & Kyprianou, N. Profiles of radioresistance mechanisms in prostate cancer. Crit. Rev. Oncog. 23, 39\u201367 (2018).","journal-title":"Crit. Rev. Oncog."},{"key":"85310_CR39","doi-asserted-by":"publisher","first-page":"436","DOI":"10.1038\/nature07205","volume":"454","author":"A Mantovani","year":"2008","unstructured":"Mantovani, A., Allavena, P., Sica, A. & Balkwill, F. Cancer-related inflammation. Nature 454, 436\u2013444 (2008).","journal-title":"Nature"},{"key":"85310_CR40","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1186\/s12937-016-0186-5","volume":"15","author":"EB Kurutas","year":"2016","unstructured":"Kurutas, E. B. The importance of antioxidants which play the role in cellular response against oxidative\/nitrosative stress: current state. Nutr. J. 15, 71 (2016).","journal-title":"Nutr. J."},{"issue":"9","key":"85310_CR41","doi-asserted-by":"publisher","first-page":"1306","DOI":"10.1016\/j.bcp.2013.01.017","volume":"85","author":"F Borrelli","year":"2013","unstructured":"Borrelli, F. et al. Beneficial effect of the non-psychotropic plant cannabinoid cannabigerol on experimental inflammatory bowel disease. Biochem. Pharmacol. 85(9), 1306\u20131316 (2013).","journal-title":"Biochem. Pharmacol."},{"key":"85310_CR42","doi-asserted-by":"publisher","first-page":"e19628","DOI":"10.1371\/journal.pone.0019628","volume":"6","author":"G Aviello","year":"2011","unstructured":"Aviello, G. et al. Potent antioxidant and genoprotective effects of boeravinone G, a rotenoid isolated from Boerhaavia diffusa. PLoS ONE 6, e19628 (2011).","journal-title":"PLoS ONE"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-021-85310-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-021-85310-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-021-85310-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,3]],"date-time":"2022-12-03T05:13:16Z","timestamp":1670044396000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-021-85310-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,3,12]]},"references-count":42,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2021,12]]}},"alternative-id":["85310"],"URL":"https:\/\/doi.org\/10.1038\/s41598-021-85310-6","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,3,12]]},"assertion":[{"value":"15 June 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 February 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 March 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"5856"}}